Cargando…

Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents

The current pandemic caused by the COVID-19 disease has reached everywhere in the world and has affected every aspect of our lives. As of the current data, the World Health Organization (WHO) has reported more than 300 million confirmed COVID-19 cases worldwide and more than 5 million deaths. M(pro)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alzyoud, Lara, Ghattas, Mohammad A, Atatreh, Noor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356625/ https://www.ncbi.nlm.nih.gov/pubmed/35941927 http://dx.doi.org/10.2147/DDDT.S370574

Ejemplares similares

The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation
por: Mahgoub, Radwa E., et al.
Publicado: (2022)

Structure-based assessment and druggability classification of protein–protein interaction sites
por: Alzyoud, Lara, et al.
Publicado: (2022)

Broad-Spectrum Allosteric Inhibition of Herpesvirus Proteases
por: Gable, Jonathan E., et al.
Publicado: (2014)

Allosteric Hotspots in the Main Protease of SARS-CoV-2
por: Strömich, Léonie, et al.
Publicado: (2022)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
por: Luttens, Andreas, et al.
Publicado: (2022)

Development of Broad‐Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CL(pro)
por: Bacha, Usman, et al.
Publicado: (2008)

Druggability analysis and classification of protein tyrosine phosphatase active sites
por: Ghattas, Mohammad A, et al.
Publicado: (2016)

Candidate Binding Sites for Allosteric Inhibition of the SARS-CoV-2 Main Protease from the Analysis of Large-Scale Molecular Dynamics Simulations
por: Carli, Matteo, et al.
Publicado: (2020)

X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
por: Günther, Sebastian, et al.
Publicado: (2021)

Dynamics of the SARS-CoV-2 main protease binding site
por: Harith, Advaith S., et al.
Publicado: (2023)

Targeting papain-like protease for broad-spectrum coronavirus inhibition
por: Yuan, Shuofeng, et al.
Publicado: (2022)

Structure-Based Discovery and Structural Basis of a Novel Broad-Spectrum Natural Product against the Main Protease of Coronavirus
por: Zhang, Yuting, et al.
Publicado: (2022)

Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

An extended conformation of SARS-CoV-2 main protease reveals allosteric targets
por: Sun, Zengchao, et al.
Publicado: (2022)

Correction: Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

Food phytochemicals, epigallocatechin gallate and myricetin, covalently bind to the active site of the coronavirus main protease in vitro
por: Kato, Yoji, et al.
Publicado: (2021)

Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
por: Kim, Yunjeong, et al.
Publicado: (2016)

Dynamical Nonequilibrium Molecular Dynamics Simulations Identify Allosteric Sites and Positions Associated with Drug Resistance in the SARS-CoV-2 Main Protease
por: Chan, H. T. Henry, et al.
Publicado: (2023)

Orally Efficacious Broad-Spectrum Allosteric Inhibitor of Paramyxovirus Polymerase
por: Cox, Robert M, et al.
Publicado: (2020)

Correction: Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
por: Kim, Yunjeong, et al.
Publicado: (2016)

Allosteric Inhibition of the SARS‐CoV‐2 Main Protease: Insights from Mass Spectrometry Based Assays
por: El‐Baba, Tarick J., et al.
Publicado: (2020)

Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis
por: Verma, Shalja, et al.
Publicado: (2021)

Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses
por: Wang, Ruyu, et al.
Publicado: (2023)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Quaternary Structure of the SARS Coronavirus Main Protease
por: Chang, Gu-Gang
Publicado: (2009)

Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation
por: Padhi, Aditya K., et al.
Publicado: (2021)

Understanding the role of water on temperature-dependent structural modifications of SARS CoV-2 main protease binding sites
por: Venugopal, Pushyaraga P., et al.
Publicado: (2022)

Unmasking the Conformational Stability and Inhibitor Binding to SARS-CoV-2 Main Protease Active Site Mutants and Miniprecursor
por: Kovalevsky, Andrey, et al.
Publicado: (2022)

Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design
por: Wang, Fenghua, et al.
Publicado: (2016)

Allosteric Modulation of the Main Protease (M(Pro)) of SARS-CoV-2 by Casticin—Insights from Molecular Dynamics Simulations
por: Mensah, Jehoshaphat Oppong, et al.
Publicado: (2022)

Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases
por: Pant, A., et al.
Publicado: (2018)

Phycobilins as Potent Food Bioactive Broad-Spectrum Inhibitors Against Proteases of SARS-CoV-2 and Other Coronaviruses: A Preliminary Study
por: Pendyala, Brahmaiah, et al.
Publicado: (2021)

Peptide-based inhibitors hold great promise as the broad-spectrum agents against coronavirus
por: Tang, Mingxing, et al.
Publicado: (2023)

The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus
por: Issa, Shaza S., et al.
Publicado: (2022)

Combining virtual screening with cis-/trans-cleavage enzymatic assays effectively reveals broad-spectrum inhibitors that target the main proteases of SARS-CoV-2 and MERS-CoV
por: Chang, Yu-Jen, et al.
Publicado: (2023)

An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity
por: Roche, Kathryn L., et al.
Publicado: (2023)

The conformational space of the SARS-CoV-2 main protease active site loops is determined by ligand binding and interprotomer allostery
por: Lee, Ethan, et al.
Publicado: (2023)

Individual and common inhibitors of coronavirus and picornavirus main proteases
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome
por: Sardanelli, Anna Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ospl6q69qv0anbu8052r4or8t4